The product of von Hippel-Lindau (VHL) 
INTRODUCTION
Individuals who inherit one faulty von Hippel-Lindau (VHL) allele are predisposed to VHL disease, which is characterized by the development of cerebellar, spinal, and retinal hemangioblastoma, pheochromocytoma, and clear-cell renal cell carcinoma (CC-RCC) (28) .
Tumor develops upon the somatic loss of the remaining wild-type VHL allele in a susceptible cell. Importantly, biallelic loss of VHL is associated with the vast majority of sporadic CC-RCC, establishing VHL as a critical suppressor of renal oncogenesis (28) . CC-RCC is resistant to conventional radiation and chemo-therapies and approximately a quarter of renal cancer patients present with advanced disease, including locally invasive or metastatic CC-RCC (11) .
Unfortunately, a third of patients who undergo surgical removal of localized tumors have recurrence of the disease, and the median survival for patients harboring metastatic CC-RCC is 13 months (11) . Moreover, the principal cause of morbidity and death of VHL patients is CC-RCC (28) . Despite the need to better understand the aggressive nature of CC-RCC, the molecular pathways governing its malignant phenotype remain unresolved.
The most well-characterized function of VHL is as a substrate-recognition component of the SCF (Skp1/Cdc53/F-box protein)-like E3 ubiquitin ligase complex called ECV (Elongins/Cul2/VHL) that selectively ubiquitylates oxygen-dependent prolyl-hydroxylated HIF-α subunits (23, 25, 42, 48) . In hypoxic conditions, HIFα is stabilized, recruits p300/CBP, and binds to its constitutively expressed partner HIFβ/ARNT (47) . The heterodimeric HIF complex binds to a consensus 5'-RCGTG-3' hypoxia-responsive element (HRE) in enhancers/promoters to trigger the transcription of numerous hypoxia-inducible genes that promote cellular adaptation to hypoxia, enabling cell survival under compromized oxygen availability (47) . Concordantly, tumor cells devoid of VHL have enhanced expression of HIF-
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target genes, such as VEGF (angiogenesis), GLUT-1 (anaerobic metabolism), and EPO (production of oxygen-carrying red blood cells), irrespective of oxygen tension (28) . The overexpression of these and other hypoxia-inducible genes likely explains the angiogenic phenotype of VHL-associated tumors, but also supports the notion that constitutive stabilization of HIFα is causally linked to tumorigenesis. In support, Kaelin and colleagues have shown that forced stable expression of HIF-2α in RCC cells ectopically expressing wildtype VHL overrides the tumor suppressor capacity of VHL and restores the tumorigenic potential of RCC cells in an animal xenograft system (31) . Conversely, shRNA-mediated knockdown of HIF-2α is sufficient to suppress the tumorigenic capacity of RCC cells devoid of VHL (30) . Notably, all CC-RCC-causing VHL mutants tested-to-date have shown a failure in either assembling of ECV complex or binding to HIFα (10, 20) . However, the critical event(s) downstream of HIF that causes neoplastic transformation of proximal renal tubular epithelial cell (the origin of CC-RCC) is unclear.
Proper regulation of cell-cell adhesion is vital during cell growth, differentiation, and tissue development. E-cadherins, homophilic adhesion molecules, and their associated catenins are the major constituents of cell junctions in polarized epithelial cells (45) . Increased expression of E-cadherin is associated with the differentiation of mesenchymal cells into tubular epithelial cells of the adult nephron. Conversely, loss of cell-cell adhesion is frequently associated with tumor progression and metastasis (45) . In support of this paradigm, the loss of E-cadherin is associated with the progression of numerous carcinoma types and forced expression of E-cadherin suppresses tumor development and invasion in various in vitro and in vivo tumor model systems, establishing E-cadherin as a critical tumor suppressor of the epithelium (45) . Recently, Krishnamachary et al and Esteban et al independently showed that
the loss of VHL in RCC cells results in the loss of E-cadherin expression in a HIF-dependent manner (15, 33) . Krishnamachary et al argue that the regulation of E-cadherin expression is exclusively HIF-1-dependent, while Esteban et al demonstrated dependency on both HIF-1 and HIF-2 (15, 33) . Furthermore, Krishnamachary et al showed that the activation of the HIF-1 pathway upon the loss of VHL transactivates E-cadherin transcriptional repressors TCF3 (also known as E12/E47), ZFHX1A (δEF1 or ZEB1), and SIP1 (Smad-interacting protein-1; also known as ZEB-2 or ZFHX1B), which correlated with the down-regulation of E-cadherin transcription (33) .
Here, we have examined over 100 primary CC-RCC samples via Affymetrix oligonucleotide arrays and show that the expression of E-cadherin transcipts is significantly down-regulated in CC-RCC. In addition, the analysis of 56 CC-RCC samples on tissue microarrays and immunohistochemistry on CC-RCC nephrectomy specimens from 13 patients revealed a strong positive correlation between the expression of VHL and E-cadherin. siRNAmediated knockdown of endogenous VHL or functional hypoxia resulted in dramatic attenuation of E-cadherin expression. Importantly, re-introduction of wild-type VHL, but not CC-RCC-causing VHL mutant incapable of promoting HIFα degradation, in CC-RCC (VHL-/-; HIF-1α-/-) cells fully restored E-cadherin expression, in part, via HIF-dependent regulation of E2 box-dependent transcriptional repressors Snail and SIP1, but not Slug, TCF3 or ZFHX1A, and subsequent engagement of RNA Polymerase II on endogenous E-cadherin promoter/gene. These findings provide a compelling molecular mechanism governing the transcription of E-cadherin by the VHL-HIF pathway and strengthen the potential involvement of E-cadherin in the development of CC-RCC.

MATERIALS AND METHODS
Cells
HEK293A embroyonic kidney cells, U2OS osteosarcoma, and 786-O (VHL-/-) renal clear cell carcinoma cell lines were obtained from the American Type Culture Collection (Rockville, MD) and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (Sigma) at 37°C in a humidified 5% CO 2 atmosphere.
786-O subclones ectopically expressing wild-type HA-VHL (786-VHL) or mutant HA-VHL(C162F) or (L188V) were previously described (20, 38) . RCC4 (VHL-/-) renal clear cell carcinoma subclones stably expressing HA-VHL (RCC4-VHL) or empty plasmid (RCC4-MOCK) were previously described (42) . 786-VHL stably expressing HIF-2α(P531A) (786-VHL+HIF-2α) or empty control (786-VHL+MOCK) via retrovirus were previously described (31) and generously provided by Dr. William G. Kaelin. 786-O subclones stably expressing pRetroSUPER-empty or pRetroSUPER-HIF2α shRNA were previously described (30) .
Antibodies
Monoclonal anti-hemagglutinin (HA) antibody (12CA5) was obtained from Roche Molecular Biochemicals. Monoclonal anti-VHL antibody (IG32) was as previously described (29) . Anti-β-catenin, anti-Lamin A/C and anti-α-tubulin antibodies were obtained from Santa Cruz (Santa Cruz, CA), Abcam (Cambridge, MA), and Sigma-Aldrich (Oakville, Ontario, Canada), respectively. Anti-E-cadherin antibody was obtained from BD Transduction Labs (Mississauga, Canada). Anti-HIF-2α antibody was obtained from Novus Biologicals Inc.
(Littleton, CO).
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Plasmids
Mammalian expression plasmid pRc-CMV-HA-VHL(WT) was described previously (38) .
Expression plasmid encoding Snail was generously provided by Dr. Paul Hamel. E-cadherin core promoter (-308/+21)-luciferase reporter plasmids (WT and mut E2, which contains inactivating mutations in both E2 boxes) and expression plasmid encoding SIP1 were previously described (12) . Plasmids containing shRNA against E-cadherin were generated using the Invitrogen pENTR/U6 system. Inserts containing hairpin DNA were generated using Invitrogen's Block iT™ siRNA designer and insert cassettes were bought PAGE-purified from Invitrogen using pENTR recommended protocol. The four generated shRNAs were chosen based on their predicted ability of silencing and their placement within the E-cadherin transcript. Each shRNA has 21mer of complementary sequences starting at positions 1184, 1660, 1973, and 2128 of the E-cadherin gene (Accession number NM004360). A CGAA loop is included in all plasmids. The non-targeting or scrambled shRNA was created in a similar manner with a sequence of 5'-GGAGCACGGTATTCGGGTCTACTAA-3', which bears no sequence similarity with the E-cadherin transcript.
Immunoprecipitation and immunoblotting
Immunoprecipitation and Western blotting were performed as described previously (49) . In brief, cells were lysed in EBC buffer (50 mM Tris [pH 8.0], 120 mM NaCl, 0.5% NP- 40) supplemented with a cocktail of protease and phosphatase inhibitors (Roche, Laval, Canada). 
Hypoxia treatment of cells
Cells were maintained at 1% O 2 for indicated times in a ThermoForma (Marietta, OH) hypoxia chamber (5% CO 2 , 10% H 2 , 85% N 2 ). Cell lysates were prepared in the chamber in hypoxic environment prior to further experimentation.
Immunohistochemical staining
Formalin-fixed paraffin-embedded sections from 13 nephrectomy specimens with renal cell carcinoma of clear cell type (CC-RCC) were obtained from the files of The Department of Pathology and Laboratory Medicine at The University Health Network (Toronto, Canada).
These tissue blocks were used and processed in accordance with a University Health Network Research Ethics Board-approved protocol concerning gene expression in renal cell carcinoma.
Tissues were fixed in 10% neutral buffered formalin for 24-36 h. Representative sections of tumor with adjacent non-tumor renal parenchyma, 3-4 mm in thickness, were embedded in paraffin and 5-micron sections were cut and placed on coated slides for light microscopy.
Tumor morphology and classification were assessed using standard hematoxylin and eosin (H&E) staining. The tumors were classified as CC-RCC according to criteria described in the World Health Organization classification of renal tumors (14) . Immunohistochemical staining
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for E-cadherin and VHL was performed manually using a standard avidin-biotin-peroxidase complex method. Sections were incubated overnight in a humidified chamber with either unlabeled mouse anti-human E-cadherin or mouse anti-human VHL antibodies, each at a 1:2000 dilution, following microwave pretreatment for antigen retrieval. The sections were then incubated with a biotinylated secondary antibody (horse anti-mouse IgG, 1:200 dilution) and the avidin-peroxidase complex. The color reaction was visualized using diaminobenzidine (DAB) as the chromagen. The tissue was then lightly counterstained with hematoxylin.
Tissue microarrays (TMAs)
TMAs consisting of quadruplicate representative 1.0 mm cores from 56 CC-RCC with varying Fuhrman grades (Grades 1-4) and stages (pT1-pT4) were used to analyze the correlation between E-cad and VHL protein expression patterns. Five micron sections from the CC-RCC TMAs were stained with anti-E-cad and anti-VHL antibodies as described above in 'Immunohistochemical staining'. The slides were then scanned using Aperio ScanScope (Aperio Technologies, Vista, California) and scored by two observers. In order to be considered for evaluation, at least half the TMA core was required to be present on the slide with at least 50% of the tissue present being tumor cells. Cores were scored as being either positive or negative. Only tumors with 3 or more cores in agreement were used for further analysis. Based on these criteria, 70% (39 out of 56) of the tumors on the TMA were suitable for the correlation analysis between E-cad and VHL.
Migration assay
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Cells were seeded on uncoated 6-well plates and scraping the cells with a sterile pipette tip generated the wounds. Cells were washed once and maintained in warm DMEM containing 0.5% FBS for the duration of the migration assay. Nikon Eclipse TE200 inverted microscope equipped with a heated stage and a Hamamatsu digital camera (Model C4742-95) was used to capture the images at the indicated time points. Each wound measurement was taken in triplicate and the experiment was repeated three times. Percent wound closure was determined by the measurement of the surface area of the wound at various time points relative to the starting wound surface area using AxioVision AC program (version 4.2.0.0).
Invasion assay
BD BioCoat Matrigel Invasion Chambers (BD Biosciences) containing inserts with a matrigel and an underlying membrane with 8µm pores were used as previously described (34) . Briefly, the inserts were hydrated with warm DMEM without FBS in 5%CO 2 at 37 o C for two hours. Laval, Canada) and 1 mM DTT. After a 30 min incubation period, samples were centrifuged and the resulting supernatant was isolated (nuclear fraction).
Dual-luciferase assay
U2OS osteosarcoma cells grown on 6-well plates were transfected with a total of 2.5 µg of expression plasmids using Fugene 6 (Roche). E-cad prom-luc WT or mutE2 (0.9 µg per transfection) was used to measure E-cadherin core promoter-mediated transcription and 0.1 µg of the renilla luciferase plasmid, pRL-SV40 (Promega), was used as a transfection control. An empty pcDNA3.1 plasmid (Invitrogen) was used to maintain a constant final amount of transfected DNA. Cells were lysed 48 h after transfection and luciferase assays performed using the Dual-Luciferase Reporter Assay system (Promega) and the relative light units (RLUs) measured using the lumat LB9507 luminometer (Berthold Technologies). Firefly luciferase RLUs were normalized against Renilla luciferase RLUs and standardized to the result of the E-cad prom-luc WT only transfection, which was arbitrarily set to 1.0.
Experiments and transfections were performed in triplicate with one representative experiment presented. Error bars represent standard deviations.
Microarray analysis
A C C E P T E D
We have established a large gene expression profiling database of renal tumors, some of which have previously been published (17, 62) . Synthesis of complementary DNA was performed with the use of T7-oligo (dT) primer. In vitro transcription was performed using Enzo Bioarray Transcript Labelling Kit (Enzo, NY).
The biotinylated cRNA was subsequently fragmented, and 15 ug was hybridized to each array at 45°C for 16 h. Scanning was performed in a GeneChip 3000 scanner. Quality assessment was performed in GeneChip Operating System (GCOS) 1.4 (Affymetrix) using global scaling to a target signal of 500. Quality assessment was also performed using denaturing gel electrophoresis. Median background was 73, median scaling factor was 3.06 and median GADPH 3'/5'ratio was 1.03, indicative of a high overall array and RNA quality.
Statistical analyses were performed in the statistical environment R 2.2, utilizing packages from the Bioconductor project. The MAS 5 algorithm was used to perform preprocessing of the CEL files, including background adjustment, quartile normalization and summarization. The means and the standard errors for E-cadherin gene expressions were calculated for each of the group of samples. A two-tailed Student's t test was used to determine statistically significant differences between various groups.
siRNA-mediated VHL knockdown siGENOME SMARTpool targeted to VHL was used (Dharmacon, Austin, TX). A nontargeting scrambled siRNA duplex was used as a negative control ( were determined by taking the average C t value for each cDNA sample performed in triplicate and measured against a standard plot of C t values from amplification of serially diluted human genomic DNA standards. Since the C t value is inversely proportional to the log of the initial copy number, the copy number of an experimental mRNA can be obtained from linear regression of the standard curve. A measure of the fold difference in copy number was
determined for each mRNA. Values were normalized to expression of U1AsnRNP1 mRNA and expressed relative to scrambled siRNA samples (arbitrarily set to 1.0) and represented as the mean value of three independent experiments performed in triplicate ± standard deviations.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as published previously using the Upstate ChIP assay kit ( Real-time PCR was performed in triplicate using SYBR green chemistry. Copies of the target gene were determined using genomic DNA as a standard curve (where 1 ng of genomic DNA = 300 copies of a single copy gene). Immunoprecipitated DNA (IP DNA) was determined by subtracting the number of copies from the no antibody control from the anti-Pol II immunoprecipitated DNA and dividing by the number of copies in the diluted input sample.
Primers were designed to amplify the human E-cadherin promoter; forward: 5'-CCACGC
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ACCCCCTCTCAGT-3' and reverse: 5'-GAGCGGGCTGGAGTCTGAAC-3', human Ecadherin exon 10; forward: 5'-CCGTGGATGTGCTGGATGTGA-3' and reverse: 5'-TGGGCAGTGTAGGATGTGATTTC-3' and the human Cyclophilin A promoter; forward: 5'-CCTCATGTGTCGTCCCCATCA-3' and reverse: 5'-CGCCCGTTTTATACCACGTTCG-3'.
RESULTS
Expression of E-cadherin is down-regulated in CC-RCC and correlates with VHL status.
We have established a large gene expression profiling database of renal tumors, some of which have previously been published (17, 62) . For this study, we selected a total of 105 human renal tumors of clear-cell type and 12 normal kidney tissue samples. Using the Affymetrix HGU133 Plus 2.0 GeneChip oligonucleotide arrays for all 117 cases, we found that the expression of Ecadherin transcripts was significantly down-regulated in CC-RCC (Fig. 1a) . This is consistent with immunohistochemical studies that showed reduced E-cadherin staining in the vast majority of CC-RCC tumor samples and cell lines tested (44, 57) . However, the molecular mechanism that accounts for the frequent loss of E-cadherin in CC-RCC is unknown.
To date, VHL is the most frequenlty mutated gene in CC-RCC and biallelic inactivation of the VHL locus is associated with the development of greater than 80% of sporadic CC-RCC.
Thus, we asked whether the expression of E-cadherin is associated with the VHL status.
Hematoxylin and eosin staining of representative sections from nephrectomy specimens from 13 patients confirmed the characteristic morphologic features of CC-RCC including nests of cells with abundant, optically clear cytoplasm and delicate cell membranes surrounded by a network of small, thin-walled blood vessels (data not shown). Each section studied by immunohistochemistry contained normal renal parenchyma including core convoluted tubules
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within the renal cortex (Fig. 1b, left by Western blotting and quantitative real-time PCR, respectively ( Fig. 2a and b) . In addition,
siRNA-mediated knockdown of endogenous VHL in HEK293A embryonic kidney cells resulted in marked down-regulation of E-cadherin expression (Fig. 2c) . Microarray (Fig. 1a) and real-time PCR data strongly suggest that E-cadherin regulation by VHL is at the pretranslational level. The cytoplasmic domain of E-cadherin is in a complex with β-catenin, implicating a potential 'outside-in' signaling where a loss of E-cadherin would release β-catenin to associate with the leukocyte enhancer factor (LEF)/T cell factor (TCF) to regulate the transcription of cell cycle-(e.g., Cyclin D1) or invasion-related genes (e.g., metalloproteinase matrilysin and fibronectin) (45). Interestingly, an increased level of Cyclin D1 has been observed in RCC cells devoid of VHL at high cell density (3) and cells expressing tumor-causing VHL mutants fail to assemble proper extracellular fibronectin matrices (49, 61).
However, both the overall expression and subcellular localization of β-catenin remained unaffected by VHL ( Fig. 2a and Supplemental Fig. S1 ), suggesting that β-catenin-mediated transcription is likely not involved in potential 'outside-in' signaling via the loss of E-cadherin in the context of CC-RCC.
shRNA-mediated down-regulation of E-cadherin increases the invasive potential of CC-
RCC.
The role of E-cadherin in modulating the migration and invasion properties of epithelial cells is well established. However, it is not known whether E-cadherin has similar biological effects in the context of kidney epithelial cells or CC-RCC. Although E-cadherin expression can be predictably determined by manipulating the status of VHL, altering the expression level of VHL has other consequences that can influence the motility and invasion properties of CC-RCC (see Discussion). Thus, we used a shRNA approach to specifically down-regulate the
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endogenous expression level of E-cadherin in HEK293A embryonic kidney epithelial cells, which resulted in a significant enhancement of migration as measured by percent wound closure (61.2 ± 4.8%) compared to cells expressing scrambled shRNA (43.0 ± 3.0%) (Fig. 3a and b). The change in motility was noticeable from the early time points, suggesting that the effect of modulating the expression of E-cadherin is not only potent, but also immediate (Fig.   3c ). shRNA-mediated down-regulation of E-cadherin consistently increased the motility of 786-VHL cells in a similar wound assay, but was not statistically significant (data not shown).
However, the invasion potential was increased 2.4 ± 0.2 folds in comparison to 786-VHL cells expressing the scrambled shRNA, as measured on the standard matrigel invasion chambers ( Fig. 3d and e). It should be noted that the changes in motility/invasion are likely underestimated due to the incomplete knockdown of E-cadherin (see Fig. 3a and d) .
Nevertheless, these results suggest that the diminution of E-cadherin expression would promote the invasive property of CC-RCC.
VHL regulates E-cadherin expression via a HIF-dependent mechanism.
We next asked whether the regulation of E-cadherin expression by VHL is mediated through the activity of HIF. RCC4-VHL and 786-VHL cells were maintained under normoxic (21% oxygen) or hypoxic (1%) conditions for 16 h and analyzed by Western blotting (Fig. 4a and Supplemental Fig. S2, respectively) . The expression of E-cadherin was dramatically reduced under hypoxia while preserving the expression status of VHL (Fig. 4a) . The effect of hypoxic treatment was confirmed by the increase in HIF-2α expression (Fig. 4a, upper panel) .
Although this result suggests that hypoxia-induced stabilization of HIF results in repression of E-cadherin expression, it is formally possible that VHL, independent of HIF, regulates the
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expression of E-cadherin in an oxygen-dependent manner. Therefore, we examined various VHL mutants that have retained or lost the ability to regulate HIF. Certain non-CC-RCCassociated VHL mutants have been shown to retain the ability to regulate HIF activity (10, 20, 61) . For example, The L188V mutation allows proper oxygen-dependent degradation of HIFα and is associated with a sub-class of VHL disease (Type 2C), which is clinically characterized by the exclusive development of pheochromocytoma (20) . In contrast, invariably all CC-RCCassociated VHL mutations tested-to-date, such as C162F, result in a complete loss of ability to mediate the destruction of HIFα via the ubiquitin-proteasome pathway (10, 20) . 786-O cells ectopically expressing VHL(C162F) showed negligible expression of E-cadherin, while those expressing VHL(L188V) showed higher detectable levels of E-cadherin, albeit at a lower level than observed in cells expressing VHL(WT) (Fig. 4b) . 2) . Notably, the level of E-cadherin was inversely proportional to the level of HIF-2α (Fig. 4c) . Conversely, 786-O subclones infected with retroviruses that express HIF-2α-specific shRNA demonstrated markedly increased level of E-cadherin relative to 786-O cells infected with 'empty' retrovirus (Fig. 4d) . In addition, the activity of the exogenous E-cadherin promoter-driven luciferase reporter was much higher in 786-O cells reconstituted with wildtype VHL (786-WT; low HIF activity) than in 786-MOCK (high HIF activity) cells (Fig. 4e) .
In addition, 786-O (VHL-/-; HIF-1α-/-)
Taken together, these results strongly suggest that HIF negatively regulates E-cadherin expression, at least in part, at the level of transcription.
A C C E P T E D VHL down-regulates E-cadherin-specific transcriptional repressors Snail and SIP1.
Mutational analyses have shown that biallelic somatic inactivating mutations of E-cadherin are rare (6, 7), and emerging evidences suggest that the loss or reduction in E-cadherin expression in cancer cells primarily occurs at the level of transcription (5, 18, 27, 64). The two major regulators of E-cadherin transcription are the zinc finger transcriptional repressors Snail and SIP1 (Smad-interacting protein-1; also known as ZEB-2 or ZFHX1B), which bind evolutionarily conserved E2 boxes located within the E-cadherin core promoter resulting in the inhibition of E-cadherin transcription (4, 9, 12). Moreover, hypoxic treatment of ovarian carcinoma cells was shown to attenuate the expression of E-cadherin via the upregulation of
Snail (22).
Quantitative real-time PCR analysis showed a significant attenuation of both Snail and SIP1 in CC-RCC 786-O cells restored with VHL (Fig. 5a ). However, negligible changes in the expression were noted for the other known E-cadherin transcriptional repressors Slug, TCF3
and ZFHX1A (data not shown). As expected, restoration of VHL reduced the expression of HIF-target genes, VEGF and GLUT-1, and increased E-cadherin expression ( Fig. 5a and as shown in Fig. 2 ). These results suggest the possibility that VHL may increase the expression of E-cadherin by down-regulating the transcriptional repressors Snail and SIP1. In a complementary experiment, we tested the ability of VHL in the transactivation of E-cadherin promoter-driven luciferase reporter (Fig. 5b) . As expected, E-cadherin promoter containing both E2 boxes had lower basal transcriptional activity relative to E-cadherin promoter with point mutations in the E2 boxes that abrogate Snail/SIP1 binding (Fig. 5b) . Importantly, the addition of VHL markedly increased the wild-type E-cadherin promoter-driven luciferase transcription, but had insignificant effect on the E2 mutant E-cadherin promoter (Fig. 5b) . As
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predicted, the increase in VHL-mediated transactivity of wild-type E-cadherin promoterluciferase was dampened by the addition of SIP1 or/and Snail in a dosage-dependent manner (Fig. 5c) . Co-expression analysis indicated that Snail or SIP1 had negligible effect on the steady-state level of VHL (Supplemental Fig. S3 and data not shown) . These results demonstrate that the E2 boxes are functionally important in upregulating E-cadherin transcription by VHL, in part, via the down-regulation of SIP1 and/or Snail. However, neither SIP1 nor Snail individually or in combination achieved a complete inhibition of E-cadherin promoter-driven reporter activity. This suggests the existence of other yet-to-be-defined VHL/HIF-mediated E-cadherin-specific transcriptional repressors or that full repression requires the concerted actions of multiple repressors and involves, in addition to the E2 boxes, other elements within the E-cadherin promoter.
Wild-type, but not CC-RCC-causing mutant VHL, induces transcriptional activation of Ecadherin.
The principal mechanism by which transcriptional repressors attenuate the rate of transcription is by blocking the engagement of RNA Polymerase II (Pol II) and associated factors to the promoter. Notably, Snail has been shown to repress E-cadherin expression through the binding of Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex (51), which is thought to impair recruitment of Pol II and transcriptional initiation via repressive changes in chromatin structure. Repressors can also act at a post-initiation step of transcription including inhibition of phosphorylation of the Pol II holoenzyme, which represents a key step in promoter escape and cessation in elongation (39) . Therefore, we asked whether the engagement of Pol II on the endogenous E-cadherin promoter/gene is influenced by VHL. Chromatin immunoprecipitation
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(ChIP) assays at the E-cadherin locus was performed using antibodies recognizing the Nterminus of Pol II in 786-O cells expressing wild-type or HIF regulation-defective mutant VHL(C162F) (Fig. 6a) . The total amount of Pol II at the E-Cadherin promoter and exon 10 was dramatically decreased in the absence of VHL functional activity (Fig. 6a) . This was in contrast to the promoter of the housekeeping gene, Cyclophilin A, where binding of Pol II was similar in wild-type and mutant VHL cells (Fig. 6a ). This suggests that VHL's functional activity to negatively regulate HIF is necessary for transcriptional activation of E-cadherin.
To further establish a functional role of VHL/HIF in E-cadherin gene transcription, 786-O cells stably expressing wild-type VHL were exposed to hypoxia. Assessment of Pol II binding to genomic regions corresponding to coding regions of E-cadherin (exon 10) revealed that hypoxia decreased E-cadherin transcription (Fig. 6b) . A similar decrease in Pol II binding was demonstrated at the promoter of E-cadherin (data not shown). As expected, hypoxia elicited a time-dependent increase in VEGF mRNA expression (Fig. 6b) . Taken together, these results suggest that VHL activity, specifically E3 ligase function to negatively regulate HIF, is required for the transcription of the E-cadherin gene. Conversely, cellular hypoxia or loss of HIF-associated function of VHL results in the activation of HIF and disengagement of Pol II from the E-cadherin promoter, resulting in the down-regulation of E-cadherin transcription.
However, it is not formally known whether HIF-mediated engagement of Pol II on E-cadherin promoter is strictly SIP1/Snail-dependent.
E-cadherin expression is cell density-dependent.
E-cadherin expression in CC-RCC cells is also cell density-dependent as measured by Western blotting and quantitative real-time PCR (see Supplemental Fig. S4a and b) . Interestingly, the expression of VHL is strictly regulated by cell density where the steady-state amount of VHL in human renal proximal tubule epithelial cells was shown to increase more than 100-fold in dense cultures relative to sparse cultures (2) . In addition, other components of the VHL E3 ligase complex showed a similar cell density-dependent regulation (43) . Importantly, HIF-2α level was elevated in sparsely growing cells with low levels of VHL and significantly reduced or undetectable in confluent cells containing abundant VHL (43) . Moreover, the ability of VHL to shuttle between the nucleus and the cytoplasm is also regulated by cell density (36) , which in turn may influence the ability of VHL to regulate HIF activity (19) . Thus, cell density-dependent expression of E-cadherin may be due to a corresponding cell densitydependent regulation of VHL stability/function. found in the Snail promoter at position -86 to -82; SIP1 promoter/enhancer has not been defined), preventing Pol II engagement on the E-cadherin promoter and resulting in the downregulation of E-cadherin expression (see Fig. 7 ). There is, however, an additional pathway to consider (described below).
DISCUSSION
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Increased transforming-growth factor (TGF)-β signaling and expression of Snail and SIP1, as well as the loss of E-cadherin expression, have all been correlated with the epithelial to mesenchymal transition (EMT) process that occurs during normal development and acquisition of invasive phenotype in epithelial cancers (4, 9, 12, 63) . Smad-mediated signaling by TGF-β has been shown to induce the expression of the repressors Snail and SIP1 (12, 26, 59 ). HIF-1 has been shown to upregulate the expression of the members of TGF-β family in a transcription-dependent manner under hypoxic conditions. HIF-1 and Smad proteins cooperate in regulating the expression of several hypoxia and TGF-β-regulated genes, including the expression of TGF-β 2 in human umbilical vein endothelial cells (66) . In addition, HIF-1 has been shown to directly bind to the TGF-β 3 promoter and upregulate its expression under hypoxia during placental and epithelial development processes (46, 56) . Therefore, increased transcriptional activity of HIF by the functional loss of VHL in CC-RCC may result in an upregulation of TGF-β signaling, resulting in a Smad-mediated induction of SIP1 and Snail and subsequent loss of E-cadherin (Fig. 7) . Notably, VHL has also been shown to repress the expression of TGF-β 1 via regulating its mRNA stability (Fig. 7, dashed line) (1). Whether this process is HIF-mediated is currently unknown.
In the current work, we demonstrated that the loss of VHL leads to the dramatic down- 
